Back
CRISPR Therapeutics AG Stock Price Chart

Major Market Shift - Act Now Before it's Too Late
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
25
CRSP
CRISPR Therapeutics AG
Last Price:
$37.78
Seasonality Move:
26.86%
7 Day Trial
ALL ACCESS PASS
$
7

Mode Mobile Could be Next in Line
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing slight buying pressure.
CRISPR Therapeutics AG Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 35.96 | Buy |
20-day SMA: | 36.72 | Buy |
50-day SMA: | 40.94 | Sell |
200-day SMA: | 46.3 | Sell |
8-day EMA: | 36.64 | Buy |
20-day EMA: | 31.44 | Buy |
50-day EMA: | 20.09 | Buy |
200-day EMA: | 6.64 | Buy |
CRISPR Therapeutics AG Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.65 | Buy |
Relative Strength Index (14 RSI): | 49.49 | Sell |
Chaikin Money Flow: | 299518 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (34.05 - 41.49) | Buy |
Bollinger Bands (100): | (37.68 - 47.48) | Sell |
CRISPR Therapeutics AG Technical Analysis
Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for CRISPR Therapeutics AG Stock
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 37.78 while CRSP 8-day simple moving average is 35.96, which is a Buy signal.
-
The stock price of CRSP is 37.78 while CRISPR Therapeutics AG 20-day SMA is 36.72, which makes it a Buy.
-
CRISPR Therapeutics AG 50-day simple moving average is 40.94 while CRSP share price is 37.78, making it a Sell technically.
-
CRSP stock price is 37.78 and CRISPR Therapeutics AG 200-day simple moving average is 46.30, creating a Sell signal.
CRSP Technical Analysis vs Fundamental Analysis
Sell
25
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy or a Sell?
-
CRISPR Therapeutics AG stock is rated a SellThe current CRISPR Therapeutics AG [CRSP] share price is $37.78. The Score for CRSP is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
CRISPR Therapeutics AG Stock Info
Market Cap:
3.2B
Price in USD:
37.78
Share Volume:
1.6M
CRISPR Therapeutics AG 52-Week Range
52-Week High:
67.88
52-Week Low:
30.04
Sell
25
CRISPR Therapeutics AG (CRSP)
is a Sell
CRISPR Therapeutics AG Share Price Forecast
-
What is the CRISPR Therapeutics AG stock price today?The CRISPR Therapeutics AG stock price is 37.78 USD today.
-
Will CRSP stock go up or go down?CRISPR Therapeutics AG> share price is forecast to RISE/FALL based on technical indicators
-
Is CRISPR Therapeutics AG overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, CRISPR Therapeutics AG is overvalued.
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 37.78 while CRSP 8-day exponential moving average is 36.64, which is a Buy signal.
-
The stock price of CRSP is 37.78 while CRISPR Therapeutics AG 20-day EMA is 31.44, which makes it a Buy.
-
CRISPR Therapeutics AG 50-day exponential moving average is 20.09 while CRSP share price is 37.78, making it a Buy technically.
-
CRSP stock price is 37.78 and CRISPR Therapeutics AG 200-day simple moving average is 6.64, creating a Buy signal.
Fundamental Analysis of CRISPR Therapeutics AG
Is CRISPR Therapeutics AG a good investment?
-
Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.02 per share, an increase this year of $0.24 per share, and an increase next year of $0.91 per share.
Technical Analysis of CRISPR Therapeutics AG
Should I short CRISPR Therapeutics AG stock?
-
CRSP Moving Average Covergence Divergence (MACD) indicator is 6.65, suggesting CRISPR Therapeutics AG is a Buy
-
CRISPR Therapeutics AG Relative Strength Index (RSI) is 49.49, which suggest CRISPR Therapeutics AG is oversold
-
The Bollinger Bands (25) for CRISPR Therapeutics AG is (34.05 - 41.49), which suggest CRISPR Therapeutics AG is a Sell
-
The Bollinger Bands (100) for CRISPR Therapeutics AG is (37.68 - 47.48), which suggest CRISPR Therapeutics AG is a Sell
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.